title: [Integration of new and future biomarkers in the treatment of breast cancer].
abstract: In the management of breast cancer patients, there is a need for the development of new and efficient biomarkers to be used for early detection/screening, prognostic evaluation, prediction of therapy sensitivity/resistance and disease monitoring. It is emphasized that before a new biomarker can be implemented in the routine treatment of breast cancer patients, its value must be proven in high-powered, prospective clinical trials. This paper describes each of the above-mentioned indications followed by information on the present status for their development in breast cancer.
authors.affiliation: Københavns Universitet, Det Biovidenskabelige Fakultet for Fødevarer, Veterinaermedicin, Frederiksberg C.
authors.forename: Sidse Ørnbjerg
authors.initials: SØ
authors.lastname: Würtz
authors.forename: Katrine Lütken
authors.initials: KL
authors.lastname: Henriksen
authors.forename: Anne
authors.initials: A
authors.lastname: Lykkesfeldt
authors.forename: Julio
authors.initials: J
authors.lastname: Celis
authors.forename: Nils Age
authors.initials: NA
authors.lastname: Brünner
mesh_terms: D014408:Biomarkers, Tumor / Q000032:analysis; D001943:Breast Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000378:metabolism; D005260:Female; D006801:Humans; D011237:Predictive Value of Tests; D011379:Prognosis; D012680:Sensitivity and Specificity
chemical_list: D014408:Biomarkers, Tumor